The product was sold for only RM20 on e-commerce platforms and social media, without National Pharmaceutical Regulatory Agency (NPRA) approval, proper labelling, or safety verification
Research perspective A 2001 editorial in the European Journal of Anaesthesiology described DSIP as "incredibly safe" based on the lack of lethal doses in animal studies and absence of significant side effects in human trials beyond transient symptoms
Journal Of The American College Of Cardiology 2013, 62: 2217-2226
Part D spending growth might moderate slightly due to the drug pricing measures, but overall prescription drug spending is still expected to climb as new drugs enter the market
Other Vision Problems Potentially Linked to Zepbound: Blurry Vision: Initial changes in glucose levels from Zepbound use might cause temporary blurry vision until levels stabilize
GHK-Cu is a three-amino-acid copper peptide with proven skin benefits but no injectable human data